In this study, liver microsome-mediated activation of diphenyl (DP), diphenylmethane (DPM) and 2,2-diphenylpropane (DPP) to estrogens was demonstrated. These three compounds were negative in estrogen reporter assay using estrogen-responsive human breast cancer cell line MCF-7. However, they exhibited estrogenic activity after incubation with liver microsomes of 3-methylcholanthrene-treated rats in the cases of DP and DPM, or of phenobarbital-treated rats in the cases of DP and DPP, in the presence of NADPH. When these compounds were incubated with liver microsomes in the presence of NADPH, monohydroxyl and dihydroxyl derivatives were formed. These hydroxylated metabolites, 4-hydroxydiphenyl, 3-hydroxydiphenyl, 2-hydroxydiphenyl, 4-hydroxydiphenylmethane, 2-(4-hydroxyphenyl)-2-phenylpropane (4-OH-DPP), 4,4′-dihydroxydiphenyl, 4,4′-dihydroxydiphenylmethane and 2,2-bis(4-hydroxyphenyl)propane (bisphenol A), all exhibited estrogenic activity in MCF-7 cells. Binding assay of these hydroxylated compounds with rat uterus estrogen receptor was also positive. These results suggest that the estrogenic activities of DP, DPM and DPP were due to the formation of hydroxylated metabolites by the liver cytochrome P450 system.
INTRODUCTION
Some chemicals in the environment are able to mimic the biological activity of hormones such as sex hormones and thyroid hormone, thereby interfering with hormone receptor function. These endocrine disrupters include several persistent chlorinated pesticides, such as kepone, o,p′-dichlorodiphenyltrichloroethane (o,p′-DDT), dieldrin and methoxychlor, some polychlorinated biphenyl congeners such as polychlorinated diphenyl (PCBs) and dibenzodioxins, and industrial compounds used in the plastics and detergent industries, such as alkylphenols and bisphenol A. [1] [2] [3] Among these compounds, those which are lipophilic and persistent may be accumulated through the food web, posing a health threat to humans and animals. Endogenous estrogens have been shown to have multiple sites of activity and to *To whom correspondence should be addressed: Graduate School of Biomedical Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, Japan. Tel.: +81-82-257-5328; Fax: +81-82-257-5329; E-mail: skitamu@hiroshima-u.ac.jp No. 4 Diphenyl (DP) is used as an antifungal agent for citrus fruits, and is also used as wrapping paper for impregnated fruit. Under poor hygienic conditions, its production caused the toxicity for workers. 7, 8) It is known to induce calculi and tumors in the urinary bladder of rats. 9) Diphenylmethane (DPM) is also used as a dye carrier and synthetic intermediate, similarly to DP. DP is metabolized via multiple pathways, resulting in the production of various derivatives, such as conjugates (sulfate and glucuronide) of hydroxylated diphenyls. 4-Hydroxydiphenyl, 4,4′-dihydroxydiphenyl and 3,4-dihydroxydiphenyl were identified as urinary metabolites of DP in rats and rabbits. 10) Furthermore, 2-hydroxydiphenyl, 2,4′-dihydroxydiphenyl and 3-hydroxydiphenyl were also identified as in vitro metabolites with liver microsomes of various animals.
11) The 2-and 3-hydroxylation activities were induced to similar extents by 3-methylcholanthrene (MC) pretreatment of the animals. Phenobarbital pretreatment primarily induced 2-and 3-hydroxylation activities, the latter more dramatically.
12) The sulfate conjugate of 4-hydroxydiphenyl is involved in the formation of urinary calculi.
9) The sulfate conjugate is also reported to be a candidate for medicinal treatment of breast cancer, because it shows a potent inhibitory effect on sulfation of estrogens. 13) Ozawa et al. 14) reported that 2,5-dihydroxydiphenyl is a cytotoxic metabolite. However, the estrogenic activities of DP and related compounds have not been reported.
In the present study, the estrogenic activities of DP, DPM and 2,2-diphenylpropane (DPP) were examined in the presence or absence of a liver microsomal oxidase system by employing the estrogen-responsive element (ERE)-luciferase reporter assay in MCF-7 cells. We demonstrate that DP, DPM and DPP exhibit estrogenic activities after activation to their hydroxylated products by rat liver microsomal mixed function oxidase.
MATERIALS AND METHODS
Chemicals ---DP (> 99%), 4-hydroxydiphenyl (> 99%), 3-hydroxydiphenyl (> 95%), 2-hydroxydiphenyl (> 98%), DPM (> 99%), 4-hydroxydiphenylmethane (> 98%), 4,4′-dihydroxydiphenyl (> 99%), 4,4′-dihydroxydiphenylmethane (> 97%), 2-(4-hydroxyphenyl)-2-phenylpropane (4-OH-DPP, > 98%) and 2,2-bis(4-hydroxyphenyl)propane (bisphenol A, > 99%) were obtained from Tokyo (Shizuoka, Japan). The animals were housed at 22°C with a 12-hr light/dark cycle, with free access to tap water and a standard pellet diet MM-3 (Funabashi Farm, Funabashi, Japan). In some experiments, male rats were given intraperitoneal administration of phenobarbital (80 mg/kg) or 3-MC (25 mg/kg) daily for three days before use. All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals of Hiroshima University. Preparation of Liver Microsomes ---The livers of male rats were excised from exsanguinated rats and immediately perfused with 1.15% KCl. The livers were homogenized in four volumes of the KCl solution using a Potter-Elvehjem homogenizer. The microsomal fraction was obtained from the homogenate by successive centrifugation at 9000 × g for 20 min and 105000 × g for 60 min. The fraction was washed by resuspension in the KCl solution and resedimentation. The pellets of microsomes were resuspended in the solution to make 1 ml equivalent to 1 g of liver. Protein contents in the liver microsomal preparations were determined by the method of Lowry et al.
15)
Cell Culture ---MCF-7 cells were maintained in Minimum Essential medium (MEM; Sigma Chemical Co.) containing penicillin and streptomycin with 5% fetal bovine serum (LiGibco/Invitrogen Co., Carlsbad, CA, U.S.A.).
Assay of Estrogenic Activities of DP and Related
Compounds ---Assay of estrogenic activity was performed according to the previously reported method. 6) Briefly, for ERE-luciferase reporter assay using MCF-7 cells, transient transfections were performed using Transfast™ (Promega Co., Madison, WI, U.S.A.), with p(ERE) 3 -SV40-luc and pRL/CMV (Promega Co.) as an internal standard. Twenty-four hours after addition of the sample, the luciferase activity was measured with a Dual Luciferase assay kit™ (Promega Co.).
For the assay of the metabolites produced from proestrogens, substrates (0.1 µmol) were incubated with 0.1 ml of rat liver microsomes in the presence of 1 µmol of NADPH for 30 min in a final volume of 1 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). After the incubation, the mixture was extracted with 5 ml of ethyl acetate and evaporated to dryness. The residue was dissolved in 1 ml of ethanol and an aliquot was used for the estrogenic activity assay. The total concentration of the substrate and its metabolites was calculated from the original amount of the substrate. Competitive Binding Assay to Estrogen Receptor ---Rat uterus was homogenized with TEGDMo buffer (1 mM disodium EDTA, 1 mM dithiothreitol, 10 mM sodium molybdate, 10%(v/v) glycerol and 10 mM Tris-HCl, pH 7.4). The cytosolic fraction was obtained from the homogenate by centrifugation at 105000 × g for 50 min. For the assay, 0.1 ml (2 mg protein) of the cytosolic fraction was added to the same volume of TEGDMo buffer containing 5 nM 3 H-E2 (17.7 KBq/ml) and various concentrations of test compounds. After incubation at 30°C for 40 min, 0.05 ml of 1.5% charcoal and 0.15% dextran T70 mixture in TEG [1 mM disodium EDTA, 10%(v/v) glycerol and 10 mM Tris-HCl, pH 7.4] was added. After incubation for 10 min at 4°C with occasional vortexing, the suspension was centrifuged at 1000 × g for 10 min. A 0.1 ml aliquot of the supernatant was transferred to another tube, and 1 ml of scintillator was added. The radioactivity in each tube was counted with a Wallac MicroBeta Scintillation Counter (Wallac Oy., Turuku, Finland).
Identification of Oxidative Metabolites of Proestrogens Formed by Rat Liver Microsomes
---The oxidative metabolites of proestrogens were isolated from a large-scale incubation mixture. This mixture consisted of 1 µmol of the substrate, 5 µmol of NADPH and 1 ml (18-22 mg protein) of liver microsomes of 3-MC-or phenobarbital-treated rats in a total volume of 5 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). After incubation for 30 min, the mixture was extracted with 20 ml of ethyl acetate or diethyl ether. The supernatant was evaporated to dryness and dissolved in a small amount of methanol. The metabolites were purified by preparative HPLC, and identified by comparison with authentic samples. Assay of Liver Microsomal Oxidase Activities toward Proestrogens ---An incubation mixture consisted of 0.1 µmol of a proestrogen, 0.5 µmol of NADPH and 0.1 ml of liver microsomes equivalent to 100 mg liver wet weight (1.6-2.1 mg protein) in a final volume of 1 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). The incubation was performed at 37°C for 20 min. After incubation, 0.1 ml of 2 N HCl and 0.1 µmol of 4-hydroxydiphenylmethane or phenothiazine as an internal standard were added and the mixture was extracted with 5 ml of diethyl ether in the case of DP. In the case of DPM or DPP, 0.1 µmol of phenothiazine or trans-4-hydroxystilbene as an internal standard was added and the mixture was extracted with 5 ml of ethyl acetate. The extract was evaporated to dryness, the residue was dissolved in 0.1 ml of methanol, and an aliquot (5 µl) was analyzed by high-performance liquid chromatography (HPLC). HPLC ---HPLC was performed in a Hitachi L-6000 chromatograph (Tokyo, Japan) fitted with a 250 × 4.6 mm Shiseido Capcell Pak C18 type UG 120A 5 µm column (Shiseido Co., Ltd., Tokyo, Japan) for the separation of DP and 4,4′-dihydroxydiphenyl, and DPM, 4-hydroxydiphenylmethane and 4,4′-dihydroxydiphenylmethane. The mobile phase for the separation of DP and the metabolites was acetonitrile-water (4 : 6, v/v) The chromatograph was operated at a flow rate of 1.0 ml/min at a wavelength of 254 nm. The elution times of 4,4′-dihydroxydiphenyl and 4-hydroxydiphenylmethane (an internal standard) were 10.3 and 22.6 min, respectively. For the separation of DP, 2-hydroxydiphenyl, 3-hydroxydiphenyl and 4-hydroxydiphenyl, a LiChrospher 100NH 2 column (125 × 4 mm) was used, and the mobile phase was n-hexane-2-propanol (96 : 4, v/v). The chromatograph was operated at a flow rate of 0.5 ml/min at a wavelength of 254 nm. The elution times of 2-hydroxydiphenyl, 3-hydroxydiphenyl, 4-hydroxydiphenyl and phenothiazine (an internal standard) were 14.5, 19.7, 21.6 and 18.1 min, respectively. For the separation of DPM and the metabolites, the mobile phase was acetonitrile-water (1 : 2, v/v). The chromatograph was operated at a flow rate of 1.0 ml/min at a wavelength of 254 nm. The elution times of 4,4′-dihydroxydiphenylmethane, 4-hydroxydiphenylmethane, phenothiazine (an internal standard) and DPM were 6.1, 13.1, 18.6 and 32.0 min, respectively. For the separation of DPP and the metabolites, a 125 × 4.0 mm Develosil column (Nomura Chemical Co., Ltd. Tokyo, Japan) was used, and the mobile phase was acetonitrile-water (1 : 1, v/v). The chromatograph was operated at a flow rate of 0.4 ml/min at a wavelength of 254 nm. The elution times of bisphenol A, trans-4-hydroxystilbene (an internal standard), 4-OH-DPP and DPP were 5.8, 13.2, 15.8 and 50.0 min, respectively. Mass and UV Spectra ---A Japan Electron Optics Laboratory HX-100 mass spectrometer (JEOL, Tokyo, Japan) in electron impact mode was used for structure analysis of the metabolites. Mass spectroscopy was carried out at a collision energy of 70 eV and an acceleration voltage of 10 kV. UV spectra were determined with a Beckman DV-60 spectrophotometer in ethanol.
RESULTS

Estrogenic Activity of DP, DPM and DPP with or without a Microsomal Activation System
Estrogenic activity of DP, DPM and DPP in the presence or absence of a rat liver microsomal oxidation system was examined using ERE-luciferase reporter assay with MCF-7 cells. These compounds did not show estrogenic activity in this assay. When DP was incubated with liver microsomes of phenobarbital-or 3-MC-treated rats in the presence of NADPH, the extracts of the incubation mixtures exhibited significant estrogenic effects on the cells in the range of 10 -5 -10 -4 M. Little effect was obtained when liver microsomes of untreated rats were used (Fig. 1A) . When DPM was incubated with liver microsomes of 3-MC-treated rats in the presence of NADPH, the extracts of the incubation mixtures exhibited estrogenic effects on the cells in the range of 10 -5 -10 -4 M. Little effect was obtained when liver microsomes of untreated or phenobarbital-treated rats were used instead of those from 3-MC-treated rats (Fig. 1B) . In contrast, DPP exhibited a significant estrogenic effect after incubation with liver microsomes of phenobarbital-treated rats. In this case, liver microsomes from untreated or 3-MC-treated rats were not effective (Fig. 1C) . These facts suggest that DP, DPM and DPP are metabolically activated to the estrogenic compounds by rat liver microsomes.
Metabolism of DP, DPM and DPP by Rat Liver Microsomes
DP was incubated with liver microsomes of 3-MC-treated rats in the presence of NADPH for the detection of the estrogenic metabolites, as described in Materials and Methods. Four peaks were detected in HPLC chromatograms of the extract of the incubation mixtures ( Figs. 2A and 2B ). These peaks were not detected in the control, which was incubated without the substrate. These metabolites were designated DP-1, DP-2, DP-3 and DP-4. The retention times of DP-1, DP-2, DP-3 and DP-4 (14.5, 19.8, 21.6 and 10.3 min) corresponded to those of 2-hydroxydiphenyl, 3-hydroxydiphenyl, 4-hydroxydiphenyl and 4,4′-dihydroxydiphenyl, respectively. These metabolites were also detected when microsomes of phenobarbital-treated rats were used. However, DP-3 was not formed by liver microsomes of untreated rats (data not shown).
When DPM was incubated with liver microsomes of 3-MC-treated rats in the presence of NADPH, two peaks were detected in an HPLC chromatogram of the extract of the incubation mixture. These metabolites were designated DPM-1 and DPM-2 (Fig. 2C) . The retention times of DPM-1 and DPM-2, 6.1 and 13.1 min, corresponded to those of 4,4′-dihydroxydiphenylmethane and 4-hydroxydiphenylmethane, respectively.
DPP was also incubated with liver microsomes of phenobarbital-treated rats in the presence of NADPH. Two peaks, which were designated DPP-1 and DPP-2, were detected in an HPLC chromatogram of the extract of the incubation mixtures (Fig. 2D) . The retention times of DPP-1 and DPP-2 (5.8 and 15.8 min) corresponded to those of bisphenol A and 4-OH-DPP, respectively. The metabolites of DP (DP-1, DP-2, DP-3 and DP-4), DPM (DPM-1 and DPM-2) and DPP (DPP-1 and DPP-2) were identified unequivocally as 2-hydroxydiphenyl, 3-hydroxydiphenyl, 4-hydroxydiphenyl, 4,4′-dihydroxydiphenyl, 4,4′-dihydroxydiphenylmethane, 4-hydroxydiphenylmethane, bisphenol A and 4-OH-DPP by mass and UV spectral comparison with authentic samples.
Oxidase Activities of Rat Liver Microsomes towards Proestrogens
The oxidase activities of rat liver microsomes toward DP, DPM and DPP were examined using liver microsomes of untreated, phenobarbital-treated and 3-MC-treated rats. Liver microsomes of 3-MCtreated rats exhibited significant oxidase activities toward DP and DPM in the presence of NADPH compared with those of untreated rats. The amount of 4-hydroxyl, 3-hydroxyl and 2-hydroxyl derivatives of diphenyl formed were much higher than that of the 4,4′-dihydroxyl derivative (Figs. 3A and 3B ). In contrast, only marginal activity was observed with NADH instead of NADPH (data not shown). Liver microsomes of phenobarbital-treated rats exhibited significant oxidase activity toward DP and DPP in the presence of NADPH compared with those of untreated rats. Oxidase activities toward DP to generate 3-and 4-hydroxydiphenyl and 4,4′-dihydroxydiphenyl were also enhanced by phenobarbital treatment. The amount of 4-OH-DPP formed by liver microsomes of phenobarbital-treated rats was much higher than that of bisphenol A (4,4′-DiOH-DPP) (Fig. 3C) . The NADPH-linked activities of rat liver microsomes toward DP, DPM and DPP were inhibited by the addition of SKF 525-A, and the activities of the microsomes of MC-treated rats toward DP and DPP were markedly inhibited by α-naphthoflavone (data not shown). No oxidase activity of liver microsomes of untreated, 3-MC or phenobarbital-treated rats toward 4,4′-dihydroxydiphenyl, 4,4′-dihydroxydiphenylmethane or bisphenol A was detected in this experiment. of four experiments. Estrogenic activity was expressed as a relative activity with respect to the control using MCF-7 cells. A chemical was incubated with liver microsomes in the presence of NADPH, and the extract of the incubation mixture was subjected to the screening test. PB, phenobarbital; MC, 3-methylcholanthrene; E2, 17β-estradiol. *p < 0.05 and **p < 0.01 indicate significant differences from control experiments to which no chemical was added.
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Estrogenic Activities of the Hydroxylated Metabolites Formed from the Proestrogens with Liver Microsomes
The estrogenic activities of the hydroxylated metabolites of the proestrogens were examined using ERE-luciferase reporter assay in MCF-7 cells. 4-Hydroxydiphenyl, 4-hydroxydiphenylmethane, 4,4′-dihydroxydiphenyl, 4,4′-dihydroxydiphenylmethane, 4-OH-DPP and 4,4′-DiOH-DPP all showed estrogenic activity, and their activities were of similar order. The activity of the 4-hydroxyl derivatives was not very different from that of the 4,4′-dihydroxyl derivatives. However, 2-hydroxydiphenyl and 3-hydroxydiphenyl showed lower activities than 4-hydroxydiphenyl and 4,4′-dihydroxydiphenyl. These compounds were cytotoxic to MCF-7 cells at concentrations above 1 × 10 -5 M, except in the case of 4-OH-DPP (above 1 × 10 -6 M) (Fig. 4) . When ICI 182,780, a pure estrogen receptor antagonist, was added at the concentration of 1 × 10 -8 M, the estrogenic activity of these compounds was markedly inhibited (data not shown). When 4,4′-dihydroxydiphenyl, 4,4′-dihydroxydiphenylmethane or bisphenol A was incubated with liver microsomes of untreated, phenobarbital-treated and 3-MC-treated rats in the presence of NADPH, its activity was not much changed (data not shown). These facts suggest that the estrogenic activities of DP, DPM or DPP were predominantly due to the 4-hydroxyl and 4,4′-dihydroxyl derivatives formed through metabolic activation by rat liver microsomes, because these metabolites were not further activated by rat liver microsomes.
Competitive Binding Assay of the Hydroxylated Metabolites
The estrogenic activities of DP, DPM, DPP and their metabolites were examined by using binding assay to estrogen receptor of rat uterus. Hydroxylated metabolites competitively inhibited the binding of 3 H-E2 (5 × 10 -9 M) to estrogen receptor in the range of 1 × 10 -6 -1 × 10 -4 M (Fig. 5) . The highest activity was observed with bisphenol A, followed by 4-OH-DPP, 4,4′-dihydroxydiphenylmethane and 4,4′-dihydroxydiphenyl. 4,4′-Dihydroxyl derivatives showed high affinity for the estrogen receptor com- pared to monohydroxyl derivatives. In contrast, no inhibitory effect of DP, DPM or DPP (1 × 10 -6 -1 × 10 -4 M) on the binding affinity of 3 H-E2 at the concentration of 5 × 10 -9 M was observed. These experiments confirm that the estrogenic activities of DP, DPM and DPP were due to their hydroxylated metabolites generated by metabolic activation.
DISCUSSION
We have shown here that DP, DPM and DPP are converted to active estrogens by liver microsomal enzymes. Thus, these compounds seem to be typical proestrogens, which would be metabolically activated to estrogens in the body. We have already shown that trans-stilbene and trans-stilbene oxide are activated to estrogens by rat liver microsomes, and we identified the active metabolites of transstilbene as trans-4-hydroxystilbene and trans-4,4′-dihydroxystilbene. 4 ) Further, we demonstrated that styrene oligomers are converted to estrogens after metabolic activation by rat liver microsomes. 6) The activation mechanism of DP and related compounds established in this study seems to be similar to that of trans-stilbene. Introduction of a phenolic hydroxyl group into a parent hydrocarbon seems generally to produce estrogenic activity. Quantitative structureactivity relationship work on the structural features of estrogen receptor ligands shows that an unhindered hydroxyl group on an aryl ring and a hydrophobic group attached para to the hydroxyl group are essential. [16] [17] [18] [19] This requirement of a hydroxyl group was confirmed by ligand binding assay in a reporter/transcriptional system for the estrogen receptor. [20] [21] [22] In rats and rabbits in vivo, 2-, 3-, and 4-hydroxydiphenyl, and 4,4′-dihydroxydiphenyl have been found as urinary metabolites of DP. 10, 23, 24) The most abundant metabolite was 4,4′-dihydroxydiphenyl, followed by 4-hydroxydiphenyl. In contrast, Billings and McMahon 11) reported that DP was oxidized to 3-hydroxydiphenyl and diphenylcatechol by hamster, mouse and rabbit liver microsomes. 4-Hydroxydiphenyl glucuronide and sulfate were reported to be formed by rat hepatocytes, or liver and kidney slices. 25, 26) In the present study, we showed that DP, DPM and DPP are oxidized to the 4-hydroxyl derivatives, and in the case of DP to the 2-, and 3-hydroxyl derivatives as well, by cytochrome P450 of rat liver microsomes, and the 4,4′-dihydroxyl derivatives are also formed as minor metabolites. These microsomal oxidations were stimulated by the pretreatment of rats with 3-MC or phenobarbital. The differential effects of these inducers on the DP hydroxylations are in accordance with previous findings, 12, [26] [27] [28] and indicate that cytochrome P450 1A1/ 2 or 2B1 catalyze these hydroxylations. We confirmed that human cytochrome P450 1A2 and 2B6 expressed in human lymphoblastoid cells (Gentest, Woburn, MA, U.S.A.) catalyzed the oxidations of DP and DPP, respectively (data not shown). These isozymes are known to be major isoforms of cytochrome P450 in humans. It is thus possible that metabolic activation of DP and related compounds tested in this study to active estrogens occurs in humans. However, 4,4′-dihydroxydiphenyl was reported to be a major in vivo metabolite of DP. 23, 24) We cannot explain this difference between in vivo and in vitro metabolism, but their result would support the involvement of the 4,4′-dihydroxyl derivatives in the estrogenic activity of DP, DPM and DPP in vivo.
Soto et al. 29) reported that 2-hydroxydiphenyl, which is used as an antifungal, is a weak estrogen, and the related compounds 4-hydroxydiphenyl and 3-hydroxydiphenyl are also estrogenic. Estrogenic activity of 4,4′-dihydroxydiphenyl has also been re- ported.
3) These phenylphenols are used as household insecticides, especially for indoor applications, 30) and as intermediates in the manufacture of rubber and resins. Further examination is necessary to assess in detail the toxicity of phenylphenols. We showed in this paper that 4-hydroxydiphenyl is a major me- tabolite of DP in a rat liver microsomal system. The in vivo estrogenic activity of DP and DPM has been briefly reported in the literature: 31) the weight of the ovary in ovariectomized rats dosed with 4-hydroxylated diphenyl and DPM was increased compared to that in rats dosed with vehicle alone.
A possible metabolic activation pathway of the proestrogenic chemicals examined in this study with liver microsomes is shown in Fig. 6 . In the microsomal system used in this study, the estrogenic activity is likely to be mainly exhibited by the 4-hydroxyl derivatives, because the pathway leading from 4-hydroxyl derivatives to 4,4′-dihydroxyl derivatives does not proceed effectively in this system, especially for DPP. In the case of PCB, the catechol-type metabolite was shown to induce estrogenic activity.
32) It remains possible that catechol-type metabolites of DP and related compounds may be active. However, we could not detect these metabolites in our system.
Various compounds related to those used in this study have also been shown to have estrogenic activity after the metabolic activation. p-Hydroxybenzophenone, which is formed from benzophenone, an ultraviolet light-absorber, in rat hepatocytes, is also estrogenic. 33, 34) p,p′-dichlorodiphenyltrichloroethane (p,p′-DDT) is metabolized to p,p′-dichlorodiphenyldichloroethane (p,p′-DDD) and p,p′-dichlorodiphenyldichloroethylene (p,p′-DDE) by reductive dechlorination and dehydrochlorination, respectively, in animals and fish. 35, 36) p,p′-DDD shows estrogenic activity and p,p′-DDE shows antiandrogenic activity. 37, 38) Further, methoxychlor is a proestrogen which requires demethylation by liver microsomal mixed function oxidase in animals prior to eliciting estrogenic activity. 39, 40) Various pesticides might be converted to active estrogens by microsomal oxidase systems, though Sumida et al. 41) showed that perimethorine was not metabolically activated. Some hydroxylated PCBs shows estrogenic activity. 32, 42, 43) Many polycyclic aromatic hydrocarbons present as environmental pollutants are negative in the estrogen screening test, but their hydroxylated metabolites may be estrogens, as in the case of benzo[a]pyrene. 44, 45) Elsby et al. 46, 47) predicted estrogenicity by means of a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. Methoxychlor, methoxybisphenol A and 3,17β-bisdeoxyestradiol were positive. In addition to screening environmental contaminants for mutagenic and carcinogenic activities, it is also important to identify potentially hazardous proestrogens in our environment, taking account of the role of metabolic activities.
